BioStem Technologies, Inc. (OTCMKTS:BSEM) Sees Large Decline in Short Interest

BioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report) saw a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 129,500 shares, a decrease of 23.9% from the March 31st total of 170,200 shares. Approximately 0.8% of the company's stock are short sold. Based on an average daily trading volume, of 186,300 shares, the short-interest ratio is presently 0.7 days.

BioStem Technologies Trading Down 1.0 %

BSEM traded down $0.14 during trading hours on Tuesday, hitting $13.89. The company's stock had a trading volume of 54,917 shares, compared to its average volume of 67,078. The firm has a market capitalization of $232.00 million, a PE ratio of 20.43 and a beta of -0.10. The company has a 50-day simple moving average of $11.09 and a 200 day simple moving average of $13.94. BioStem Technologies has a fifty-two week low of $6.77 and a fifty-two week high of $28.26.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.